LGVN Longeveron Inc.

$0.84 -0.01%

Healthcare · Pharmaceutical Preparations

Longeveron Inc. (LGVN) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $20.8 billion. Shares last traded at $0.84, 53.3% below their 52-week high. Over the past year the stock is down 32.8%. Net profit margin is -1893.6%, below the peer median of -0.1%. Revenue declined 49.9% year over year.

Market Cap

$20.8B

Shares Out

24.79B

EPS (TTM)

$-2.27

P/E Ratio

—

P/S Ratio

17364.87

P/B Ratio

1299.09

Dividend / Share

—

Dividend Yield

—

52-Week High

$1.80

52-Week Low

$0.48

Volume

4,587

Avg Vol (3m)

17,854.127

Performance

+9.09%

+22.41%

-25.33%

+53.23%

YTD

+42.81%

-32.80%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

55.87

SMA (50)

$0.86

SMA (200)

$0.75

Price vs SMA50

-2.16%

Price vs SMA200

+12.53%

ATR (14)

$0.05

Financials

Revenue

$1M

Net Income

$-23M

Gross Margin

67.0%

Operating Margin

-1942.2%

Net Margin

-1893.6%

Return on Equity

-141.7%

Return on Assets

-107.0%

Current Ratio

3.88

Debt / Equity

0.01

Revenue Growth (YoY)

-49.9%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$-0.19	2026-05-13
FY 2025	$-1.29	2026-03-17
Q3 2025	$-1.07	2025-11-04
Q2 2025	$-0.67	2025-08-13
Q1 2026	$-0.34	2026-05-13
FY 2025	$-2.62	2026-03-17

Full earnings history →

Pharmaceutical Preparations peers

LGVN vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/S vs peers

17364.87 / 3.54 med

+490760% premium

Net margin vs peers

-1893.6% / -0.1% med

below median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.